EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, OptiBiotix Health's enterprise value is £16.33 Mil.
OptiBiotix Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was £-13.12 Mil. Therefore, OptiBiotix Health's EV-to-EBITDA for today is -1.25.
The historical rank and industry rank for OptiBiotix Health's EV-to-EBITDA or its related term are showing as below:
LSE:OPTI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -45.77 Med: 3.1 Max: 57.39
Current: -1.25
During the past 12 years, the highest EV-to-EBITDA of OptiBiotix Health was 57.39. The lowest was -45.77. And the median was 3.10.
LSE:OPTI's EV-to-EBITDA is ranked worse than 100% of 472
companies
in the Biotechnology industry
Industry Median: 9.095
vs LSE:OPTI: -1.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
OptiBiotix Health EV-to-EBITDA Historical Data
The historical data trend for OptiBiotix Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of OptiBiotix Health's EV-to-EBITDA
For the Biotechnology subindustry, OptiBiotix Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OptiBiotix Health's EV-to-EBITDA Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OptiBiotix Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where OptiBiotix Health's EV-to-EBITDA falls into.
OptiBiotix Health's current Enterprise Value is £16.33 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OptiBiotix Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was £-13.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OptiBiotix Health (LSE:OPTI) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
OptiBiotix Health's PE Ratio for today is calculated as:
OptiBiotix Health's share price for today is £0.1775.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OptiBiotix Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.151.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of OptiBiotix Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:OPTI has been successfully added to your 